133 related articles for article (PubMed ID: 32789858)
1. Clinical practices and outcomes of RhD immunoglobulin prophylaxis following large-volume fetomaternal haemorrhage in Queensland, Australia.
Tneh SY; Baidya S; Daly J
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):205-212. PubMed ID: 32789858
[TBL] [Abstract][Full Text] [Related]
2. [Possibility to identify fetomaternal haemorrhage].
Studnicková M; L'ubuský M; Ordeltová M; Procházka M
Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
[TBL] [Abstract][Full Text] [Related]
3. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia.
Pal M; Williams B
Pathology; 2015 Feb; 47(2):151-5. PubMed ID: 25551305
[TBL] [Abstract][Full Text] [Related]
5. [The influence of maternal age, parity, gestational age and birth weight on fetomaternal haemorrhage during spontaneous delivery].
Studnickova M; Lubusky M; Simetka O; Petros M; Ordeltova M; Prochazka M; Vomáčková K; Langová K
Ceska Gynekol; 2012 Jun; 77(3):256-61. PubMed ID: 22779731
[TBL] [Abstract][Full Text] [Related]
6. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
Lubušký M; Procházka M; Simetka O; Holusková I
Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: gel agglutination and haemoglobin F determination by flow cytometry.
Ben-Haroush A; Belkin A; Chezar J; Orlin J; Hod M; Bar J
Acta Obstet Gynecol Scand; 2007; 86(7):821-6. PubMed ID: 17611827
[TBL] [Abstract][Full Text] [Related]
8. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Rh alloimmunization.
Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
[TBL] [Abstract][Full Text] [Related]
10. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
[TBL] [Abstract][Full Text] [Related]
11. Quality audit of the guidelines for the use of RhD immunoglobulin in obstetrics: Are we getting it right?
Glazebrook B; Akers C; Bielby L; Bastin K; Von Wielligh K; Daly J
Aust N Z J Obstet Gynaecol; 2020 Aug; 60(4):504-508. PubMed ID: 32424867
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in diagnosis and management of large fetomaternal haemorrhage.
Johnson PR; Tait RC; Austin EB; Shwe KH; Lee D
J Clin Pathol; 1995 Nov; 48(11):1005-8. PubMed ID: 8543620
[TBL] [Abstract][Full Text] [Related]
13. Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage.
Chambers E; Davies L; Evans S; Birchall J; Kumpel B
Transfus Med; 2012 Jun; 22(3):199-204. PubMed ID: 22429383
[TBL] [Abstract][Full Text] [Related]
14. Prevention of RhD alloimmunization in RhD negative women.
Lubusky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704
[TBL] [Abstract][Full Text] [Related]
15. [Fetomaternal haemorrhage in delivery by cesarean section].
Lubuský M; Simetka O; Studnicková M; Procházka M; Feketevíziová L; Ordeltová M; Langová K
Ceska Gynekol; 2012 Apr; 77(2):156-62. PubMed ID: 22702075
[TBL] [Abstract][Full Text] [Related]
16. [Guideline for prevention of RhD alloimmunization in RhD negative women].
Lubuský M; Procházka M; Simetka O; Holusková I
Ceska Gynekol; 2010 Aug; 75(4):323-4. PubMed ID: 20925231
[TBL] [Abstract][Full Text] [Related]
17. Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.
Minuk L; Clarke G; Lieberman L
Can Fam Physician; 2020 Jul; 66(7):491-498. PubMed ID: 32675093
[TBL] [Abstract][Full Text] [Related]
18. [Calculation of feto-maternal haemorrhage volume using various morphological parameters and various formulas].
Gielezynska A; Fabijańska-Mitek J; Debska M
Pol Merkur Lekarski; 2011 Mar; 30(177):228-30. PubMed ID: 21545004
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin].
Baiochi E; Camano L; Bordin JO
Cad Saude Publica; 2005; 21(5):1357-65. PubMed ID: 16158140
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
